Heart drug safety under scrutiny in major japanese study
NCT ID NCT05666518
Summary
This study aims to monitor the long-term safety of the heart failure drug vericiguat in 1,400 Japanese patients over two years. Researchers will track side effects and compare how well the drug prevents heart-related deaths versus standard treatments. The study is observational, meaning patients receive their normal prescribed care while their health data is collected.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEART FAILURE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Japanese registries
RECRUITINGMultiple Locations, Many Locations, Japan
Conditions
Explore the condition pages connected to this study.